June 24, 2020 / 12:32 PM / 13 days ago

BRIEF-Aduro Biotech Announces First Patient Dosed In Phase 1 Study Of Bion-1301 In Iga Nephropathy

June 24 (Reuters) - Aduro Biotech Inc:

* ADURO BIOTECH ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 STUDY OF BION-1301 IN IGA NEPHROPATHY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below